Search

Your search keyword '"Zheng, Changyu"' showing total 192 results

Search Constraints

Start Over You searched for: Author "Zheng, Changyu" Remove constraint Author: "Zheng, Changyu"
192 results on '"Zheng, Changyu"'

Search Results

152. Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growth.

153. Effect of clodronate on macrophage depletion and adenoviral-mediated transgene expression in salivary glands.

154. Evaluation of Salivary Gland Acinar and Ductal Cell-Specific Promoters In Vivo with Recombinant Adenoviral Vectors

157. Gastric Cancer Actively Remodels Mechanical Microenvironment to Promote Chemotherapy Resistance via MSCs-Mediated Mitochondrial Transfer.

158. Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren's disease.

159. GZMK+CD8+ T cells Target A Specific Acinar Cell Type in Sjögren's Disease.

160. Association of G protein-coupled receptor 78 with salivary dysfunction in male Sjögren's patients.

161. Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren's Disease.

162. Gingipain of Porphyromonas gingivalis manipulates M1 macrophage polarization through C5a pathway.

163. Gene Therapy of Salivary Diseases.

164. Aquaporin gene therapy corrects Sjögren's syndrome phenotype in mice.

165. Effects of human vascular endothelial growth factor on reparative dentin formation.

166. Essential role of carbonic anhydrase XII in secretory gland fluid and HCO3 (-) secretion revealed by disease causing human mutation.

167. STIM2 enhances receptor-stimulated Ca²⁺ signaling by promoting recruitment of STIM1 to the endoplasmic reticulum-plasma membrane junctions.

168. Assessment of transfection of AdCMV-EGFP to rat submandibular gland cells.

169. Antitumor effect of TRAIL on oral squamous cell carcinoma using magnetic nanoparticle-mediated gene expression.

170. Efficiently engineered cell sheet using a complex of polyethylenimine-alginate nanocomposites plus bone morphogenetic protein 2 gene to promote new bone formation.

171. Irbit mediates synergy between ca(2+) and cAMP signaling pathways during epithelial transport in mice.

172. Antitumor effect of human TRAIL on adenoid cystic carcinoma using magnetic nanoparticle-mediated gene expression.

173. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.

174. Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction.

175. Sialin (SLC17A5) functions as a nitrate transporter in the plasma membrane.

176. Assessment of the safety and biodistribution of a regulated AAV2 gene transfer vector after delivery to murine submandibular glands.

177. Systemic delivery of bioactive glucagon-like peptide 1 after adenoviral-mediated gene transfer in the murine salivary gland.

178. Salivary epithelial cells: an unassuming target site for gene therapeutics.

179. Conditional overexpression of TGF-beta1 disrupts mouse salivary gland development and function.

180. Development of a gene transfer-based treatment for radiation-induced salivary hypofunction.

181. Gene therapy of salivary diseases.

182. In vivo secretion of the mouse immunoglobulin G Fc fragment from rat submandibular glands.

183. Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction.

184. Extended transgene expression from a nonintegrating adenoviral vector containing retroviral elements.

185. Evaluation of promoters for use in tissue-specific gene delivery.

186. Sorting of transgenic secretory proteins in miniature pig parotid glands following adenoviral-mediated gene transfer.

187. Female mice are more susceptible to developing inflammatory disorders due to impaired transforming growth factor beta signaling in salivary glands.

188. Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction.

189. Evaluation of viral and mammalian promoters for use in gene delivery to salivary glands.

190. Intratumoral administration of immature dendritic cells following the adenovirus vector encoding CD40 ligand elicits significant regression of established myeloma.

191. Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics.

192. Gene transfer to salivary glands.

Catalog

Books, media, physical & digital resources